Home LiteratureArticle Details
PMID: 17559673 Published · epublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system.

Virology journal ·Vol. 4 ·2007-06-08 ·Pages 57

DeHart JL, Zimmerman ES, Ardon O, Monteiro-Filho CM, Argañaraz ER, Planelles V

Abstract

HIV-1 Vpr is a viral accessory protein that activates ATR through the induction of DNA replication stress. ATR activation results in cell cycle arrest in G2 and induction of apoptosis. In the present study, we investigate the role of the ubiquitin/proteasome system (UPS) in the above activity of Vpr. We report that the general function of the UPS is required for Vpr to induce G2 checkpoint activation, as incubation of Vpr-expressing cells with proteasome inhibitors abolishes this effect. We further investigated in detail the specific E3 ubiquitin ligase subunits that Vpr manipulates. We found that Vpr binds to the DCAF1 subunit of a cullin 4a/DDB1 E3 ubiquitin ligase. The carboxy-terminal domain Vpr(R80A) mutant, which is able to bind DCAF1, is inactive in checkpoint activation and has dominant-negative character. In contrast, the mutation Q65R, in the leucine-rich domain of Vpr that mediates DCAF1 binding, results in an inactive Vpr devoid of dominant negative behavior. Thus, the interaction of Vpr with DCAF1 is required, but not sufficient, for Vpr to cause G2 arrest. We propose that Vpr recruits, through its carboxy terminal domain, an unknown cellular factor that is required for G2-to-M transition. Recruitment of this factor leads to its ubiquitination and degradation, resulting in failure to enter mitosis.

MeSH Terms
Cell Line G2 Phase Gene Products, vpr/isolation & purification,physiology HIV-1/drug effects,physiology HeLa Cells/cytology,physiology,virology Humans Kidney Oligopeptides/pharmacology Proteasome Endopeptidase Complex/metabolism RNA, Small Interfering/genetics RNA, Viral/genetics Transfection Ubiquitin/metabolism Virus Replication vpr Gene Products, Human Immunodeficiency Virus
Chemicals
Gene Products, vpr Oligopeptides RNA, Small Interfering RNA, Viral Ubiquitin vpr Gene Products, Human Immunodeficiency Virus Proteasome Endopeptidase Complex epoxomicin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
DeHart Jason L
Division of Cell Biology and Immunology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112, USA. jason.dehart@path.utah.edu
Zimmerman Erik S
Ardon Orly
Monteiro-Filho Carlos M R
Argañaraz Enrique R
Planelles Vicente
References (34)
34 references, click to expand
  1. DDB1 maintains genome integrity through regulation of Cdt1.
    Mol Cell Biol. 2006 Nov;26(21):7977-90 PMID: 16940174
  2. Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo.
    J Virol. 2006 Nov;80(21):10407-18 PMID: 16956949
  3. DDB1 functions as a linker to recruit receptor WD40 proteins to CUL4-ROC1 ubiquitin ligases.
    Genes Dev. 2006 Nov 1;20(21):2949-54 PMID: 17079684
  4. HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase.
    Cell Cycle. 2007 Jan 15;6(2):182-8 PMID: 17314515
  5. HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1.
    Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4130-5 PMID: 17360488
  6. HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT.
    PLoS Pathog. 2006 Dec;2(12):e127 PMID: 17140287
  7. Analysis of apoptosis induced by HIV-1 Vpr and examination of the possible role of the hHR23A protein.
    Exp Cell Res. 2001 Jul 15;267(2):243-57 PMID: 11426943
  8. Multigene lentiviral vectors based on differential splicing and translational control.
    Mol Ther. 2001 Oct;4(4):375-82 PMID: 11592842
  9. Control of DNA replication licensing in a cell cycle.
    Genes Cells. 2002 Jun;7(6):523-34 PMID: 12059957
  10. Paramyxoviruses SV5 and HPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components.
    Virology. 2002 Dec 20;304(2):160-6 PMID: 12504558
  11. ATR regulates fragile site stability.
    Cell. 2002 Dec 13;111(6):779-89 PMID: 12526805
  12. Activation of the ATR-mediated DNA damage response by the HIV-1 viral protein R.
    J Biol Chem. 2003 Jul 11;278(28):25879-86 PMID: 12738771
  13. Radiation-mediated proteolysis of CDT1 by CUL4-ROC1 and CSN complexes constitutes a new checkpoint.
    Nat Cell Biol. 2003 Nov;5(11):1008-15 PMID: 14578910
  14. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.
    Nat Med. 2003 Nov;9(11):1404-7 PMID: 14528300
  15. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.
    Science. 2003 Nov 7;302(5647):1056-60 PMID: 14564014
  16. Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway.
    J Biol Chem. 2004 Feb 27;279(9):7792-8 PMID: 14672928
  17. Targeted ubiquitination of CDT1 by the DDB1-CUL4A-ROC1 ligase in response to DNA damage.
    Nat Cell Biol. 2004 Oct;6(10):1003-9 PMID: 15448697
  18. Human immunodeficiency virus type 1 Vpr-mediated G2 arrest requires Rad17 and Hus1 and induces nuclear BRCA1 and gamma-H2AX focus formation.
    Mol Cell Biol. 2004 Nov;24(21):9286-94 PMID: 15485898
  19. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53.
    Cell. 1993 Nov 5;75(3):495-505 PMID: 8221889
  20. Biochemical mechanism of HIV-I Vpr function. Specific interaction with a cellular protein.
    J Biol Chem. 1994 Jun 3;269(22):15577-82 PMID: 8195203
  21. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif.
    Mol Cell. 1998 Mar;1(4):565-74 PMID: 9660940
  22. Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation.
    Genes Dev. 2004 Dec 1;18(23):2861-6 PMID: 15574592
  23. Hepatitis B virus X protein stimulates viral genome replication via a DDB1-dependent pathway distinct from that leading to cell death.
    J Virol. 2005 Apr;79(7):4238-45 PMID: 15767425
  24. Composition and assembly of STAT-targeting ubiquitin ligase complexes: paramyxovirus V protein carboxyl terminus is an oligomerization domain.
    J Virol. 2005 Aug;79(16):10180-9 PMID: 16051811
  25. Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases.
    J Virol. 2005 Sep;79(17):10978-87 PMID: 16103149
  26. Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway.
    Mol Cell. 2005 Sep 2;19(5):607-18 PMID: 16137618
  27. Simian virus 5 V protein acts as an adaptor, linking DDB1 to STAT2, to facilitate the ubiquitination of STAT1.
    J Virol. 2005 Nov;79(21):13434-41 PMID: 16227264
  28. Xeroderma pigmentosum complementation group E protein (XPE/DDB2): purification of various complexes of XPE and analyses of their damaged DNA binding and putative DNA repair properties.
    Mol Cell Biol. 2005 Nov;25(22):9784-92 PMID: 16260596
  29. PCNA functions as a molecular platform to trigger Cdt1 destruction and prevent re-replication.
    Nat Cell Biol. 2006 Jan;8(1):84-90 PMID: 16362051
  30. PCNA is a cofactor for Cdt1 degradation by CUL4/DDB1-mediated N-terminal ubiquitination.
    J Biol Chem. 2006 Mar 10;281(10):6246-52 PMID: 16407252
  31. Two E3 ubiquitin ligases, SCF-Skp2 and DDB1-Cul4, target human Cdt1 for proteolysis.
    EMBO J. 2006 Mar 8;25(5):1126-36 PMID: 16482215
  32. Induction of G2 arrest and binding to cyclophilin A are independent phenotypes of human immunodeficiency virus type 1 Vpr.
    J Virol. 2006 Apr;80(8):3694-700 PMID: 16571786
  33. Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery.
    Nature. 2006 Oct 5;443(7111):590-3 PMID: 16964240
  34. CUL4-DDB1 ubiquitin ligase interacts with multiple WD40-repeat proteins and regulates histone methylation.
    Nat Cell Biol. 2006 Nov;8(11):1277-83 PMID: 17041588
Article Info
Journal
Virology journal
Abbr.
Virol J
ISSN
1743-422X
Published
2007-06-08
Epub
2007-00-08
Pages
57
Language
English
Region
England
NLM ID
101231645
PMCID
PMC1904188
Subset
IM
Grants
NIGMS NIH HHS · T32 GM07464 · United States
NIAID NIH HHS · AI49057 · United States
NIAID NIH HHS · T32 AI055434 · United States
NIAID NIH HHS · R56 AI049057 · United States
NIAID NIH HHS · R01 AI049057 · United States
NIGMS NIH HHS · T32 GM007464 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com